SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-042981
Filing Date
2024-05-14
Accepted
2024-05-14 16:31:08
Documents
69
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0205253-10q_pasithea.htm   iXBRL 10-Q 517316
2 CERTIFICATION ea020525301ex31-1_pasi.htm EX-31.1 11355
3 CERTIFICATION ea020525301ex31-2_pasi.htm EX-31.2 11342
4 CERTIFICATION ea020525301ex32-1_pasi.htm EX-32.1 4508
5 CERTIFICATION ea020525301ex32-2_pasi.htm EX-32.2 4846
  Complete submission text file 0001213900-24-042981.txt   4256515

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ktta-20240331.xsd EX-101.SCH 46139
7 XBRL CALCULATION FILE ktta-20240331_cal.xml EX-101.CAL 35249
8 XBRL DEFINITION FILE ktta-20240331_def.xml EX-101.DEF 229723
9 XBRL LABEL FILE ktta-20240331_lab.xml EX-101.LAB 407881
10 XBRL PRESENTATION FILE ktta-20240331_pre.xml EX-101.PRE 225333
73 EXTRACTED XBRL INSTANCE DOCUMENT ea0205253-10q_pasithea_htm.xml XML 419759
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

IRS No.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40804 | Film No.: 24944950
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)